Swedish Orphan Biovitrum and Biomodels to develop assay for mucositis risk in cancer treatment
14-May-2010 -
Swedish Orphan Biovitrum and Biomodels LLC announced a research agreement, under which Biomodels will explore the possibility of developing a clinically applicable screening platform that will define mucositis risk among patients undergoing conditioning regimens for hematopoietic stem cell ...
cancer therapy
mucositis
oral mucositis
+2